AbbVie : ABBV

All AbbVie Articles

601 Articles

Jon C. Ogg | Sep 8, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon Athletica,…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Aug 8, 2016 at 10:05 AM EDT

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

In a recent research note, the analysts at Jefferies made a big move by adding Ball Corp. to the firm's…

Lee Jackson | Aug 5, 2016 at 10:20 AM EDT

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in…

Chris Lange | Jul 29, 2016 at 9:05 AM EDT

How AbbVie Won Big on Earnings

AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.

Lee Jackson | Jul 29, 2016 at 8:15 AM EDT

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Despite the fact that energy has tumbled 20% from the highs posted in June, Jefferies remains bullish on the natural…

Chris Lange | Jul 28, 2016 at 9:45 AM EDT

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Douglas A. McIntyre | Jul 24, 2016 at 10:47 AM EDT

Apple Picked as World’s Favorite Company

In a study that ranks “perceived strength” of companies rather than their financial performance, Apple Inc. (NASDAQ: AAPL) took the top…

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

1 … 28 29 30 31 32 … 41

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More

Major Pharma Short Interest Faces Significant Drop

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Major Pharma Short Interest Slides

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

“This Is Money Going to the Past”: Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife’s House

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More

Major Pharma Short Interest Faces Significant Drop

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Major Pharma Short Interest Slides

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

“This Is Money Going to the Past”: Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife’s House

Featured Reads

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits